Amendment to Warrant to Purchase Common Stock between Actinium Pharmaceuticals, Inc. and Carnegie Hill Partners

Contract Categories: Business Finance › Warrant Agreements
Summary

This amendment extends the expiration date of a warrant originally issued by Actinium Pharmaceuticals, Inc. to Carnegie Hill Partners, allowing the purchase of up to 353,023 shares of common stock. The new expiration date for exercising the warrant is February 21, 2022. All other terms of the original warrant remain unchanged. The amendment is effective as of November 8, 2018.

Read More Arrow
EX-4.2 3 f10q0918ex4-2_actinium.htm AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DATED NOVEMBER 8, 2018 ISSUED TO CARNEGIE HILL PARTNERS

Exhibit 4.2

 

AMENDMENT
TO
ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK

 

Pursuant to Section 9(a) of the Warrant to Purchase Common Stock of (the “Warrant”) of Actinium Pharmaceuticals, Inc. (the “Company”), originally dated December 17, 2012, issued to Carnegie Hill Partners in the amount of 353,023 warrant shares, the Board of Directors of the Company has duly adopted a resolution approving this Amendment to the Warrant to extend the term of the Warrant to February 21, 2022 as follows:

 

  1. Section 1 of the Warrant is hereby amended to read in its entirety as follows:

 

“Term of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, during the term commencing (“Issuance Date”) December 17, 2012 (the “Warrant Issue Date”), and ending at 5:00 p.m., Eastern Time on February 21, 2022 and shall be void thereafter.”

 

  2. All other terms and provisions of the Warrant shall remain unchanged and in full force and effect as written.

 

IN WITNESS WHEREOF, this Amendment to the Warrant is made effective this 8th day of November, 2018.

 

    ACTINIUM PHARMACEUTICALS, INC.
         
    By:    /s/ David Nicholson
    Name:   David Nicholson
    Title:   Chairman Compensation Committee